Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kellie Kurasaki"'
Autor:
Mohammed Ali, Monica Orcine, Susan Christensen, Gull Mahvish, Gerri Sylvester, Kellie Kurasaki, Angela Lo, Kamal Masaki, Brita Aramaki, Aida Wen, Cody Takenaka, Miquela Ibrao
Publikováno v:
Journal of the American Medical Directors Association. 24:B22
Publikováno v:
The Oncologist
The oncologist, vol 23, iss 2
Kato, S; Kurasaki, K; Ikeda, S; & Kurzrock, R. (2018). Rare Tumor Clinic: The University of California San Diego Moores Cancer Center Experience with a Precision Therapy Approach. ONCOLOGIST, 23(2), 171-178. doi: 10.1634/theoncologist.2017-0199. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/6rv4q83g
The oncologist, vol 23, iss 2
Kato, S; Kurasaki, K; Ikeda, S; & Kurzrock, R. (2018). Rare Tumor Clinic: The University of California San Diego Moores Cancer Center Experience with a Precision Therapy Approach. ONCOLOGIST, 23(2), 171-178. doi: 10.1634/theoncologist.2017-0199. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/6rv4q83g
A Rare Tumor Clinic, emphasizing precision medicine, was recently initiated. This article describes preliminary experiences at the clinic and reports a case highlighting the successful use of ErbB2‐targeting therapy in an ultrarare tumor.
Back
Back
Autor:
Jared Kim, Qing X. Li, Il Kyu Cho, Niloufar Ataie, Kellie Kurasaki, Ho Leung Ng, Allison Kagawa
Publikováno v:
Protein Science. 24:1756-1763
Membrane protein crystallography is notoriously difficult due to challenges in protein expression and issues of degradation and structural stability. We have developed a novel method for large-scale screening of native sources for integral membrane p
Autor:
Jared, Kim, Allison, Kagawa, Kellie, Kurasaki, Niloufar, Ataie, Il Kyu, Cho, Qing X, Li, Ho Leung, Ng
Publikováno v:
Protein science : a publication of the Protein Society. 24(11)
Membrane protein crystallography is notoriously difficult due to challenges in protein expression and issues of degradation and structural stability. We have developed a novel method for large-scale screening of native sources for integral membrane p
Publikováno v:
Journal of Clinical Oncology. 35:11578-11578
11578 Background: Rare tumors have an incidence of < 15/100,000 per year; utra-rare, prevalence < 2000 in the USA. Patients (pts) may lack approved treatments and clinical trial access. Although each rare tumor is uncommon, cumulatively they account